Rapport Therapeutics logo

Rapport Therapeutics share price today

(RAPP)

Rapport Therapeutics share price is $18.07 & ₹1,535.52 as on 21 Dec 2024, 2.30 'hrs' IST

$18.07

0.21

(1.18%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Rapport Therapeutics share price in Dollar and Rupees. Guide to invest in Rapport Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Rapport Therapeutics. Get details on the Indian mutual funds that are investing in Rapport Therapeutics. Get Analyst recommendations and forecasts along with all the Rapport Therapeutics's financials.

Rapport Therapeutics share price movements

  • Today's Low: $17.52
    Today's High: $19.09

    Day's Volatility :8.2%

  • 52 Weeks Low: $16.55
    52 Weeks High: $29.74

    52 Weeks Volatility :44.35%

Rapport Therapeutics Returns

PeriodRapport Therapeutics Inc.Index (Russel 2000)
3 Months
-10.28%
0.0%
6 Months
-18.97%
0.0%
1 Year
-13.12%
0.0%
3 Years
-13.12%
-19.7%

Rapport Therapeutics Key Statistics

in dollars & INR

Previous Close
$17.86
Open
$17.57
Today's High
$19.085
Today's Low
$17.52
Market Capitalization
$762.3M
Today's Volume
$514.1K
52 Week High
$29.74
52 Week Low
$16.55
Revenue TTM
$0.0
EBITDA
$-61.8M
Earnings Per Share (EPS)
$-1.72
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Rapport Therapeutics from India?

It is very easy for Indian residents to invest directly in Rapport Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rapport Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rapport Therapeutics or RAPP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rapport Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rapport Therapeutics shares which would translate to 0.047 fractional shares of Rapport Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Rapport Therapeutics, in just a few clicks!

Returns in Rapport Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rapport Therapeutics investment value today

Current value as on today

₹1,15,321

Returns

₹15,321

(+15.32%)

Returns from Rapport Therapeutics Stock

₹13,125 (false-13.12%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Rapport Therapeutics

67%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Rapport Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 67% more investors are searching Rapport Therapeutics in the last 30 days versus the previous period.

Analyst Recommendation on Rapport Therapeutics

Analyst Forecast on Rapport Therapeutics

What analysts predicted

Upside of 93.69%

Current:

$18.07

Target:

$35.00

Insights on Rapport Therapeutics

  • Price Movement

    In the last 1 month, RAPP stock has moved down by -19.8%

Rapport Therapeutics Technicals Summary

Sell

Neutral

Buy

Rapport Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Rapport Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rapport Therapeutics Inc.
-19.76%
-18.97%
-13.12%
-13.12%
-13.12%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rapport Therapeutics Inc.
NA
NA
NA
-3.46
0.0
0.0
NA
9.21
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rapport Therapeutics Inc.
NA
$762.3M
-13.12%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Rapport Therapeutics

Organization
Rapport Therapeutics
Employees
0
CEO
Dr. Steven M. Paul M.D.
Industry
Miscellaneous

Management People of Rapport Therapeutics

NameTitle
Dr. Steven M. Paul M.D.
Founder & Independent Chairman
Mr. Abraham N. Ceesay M.B.A.
CEO, President, Treasurer & Director
Dr. Troy A. Ignelzi
Chief Financial Officer
Ms. Cheryl Gault
Chief Operating Officer
Mr. David Bredt M.D., Ph.D.
Founder & Chief Scientific Officer
Ms. Karina Chmielewski
Chief Information Officer & Head of Operations
Ms. Julie DiCarlo
Head of Communications & Investor Relations
Ms. Kathleen A. Wilkinson
Chief People Officer
Dr. Bradley S. Galer M.D.
Chief Medical Officer
Mr. Swamy Yeleswaram Ph.D.
Chief Development Officer

Important FAQs about investing in Rapport Therapeutics from India :

What is Rapport Therapeutics share price today?

Rapport Therapeutics share price today stands at $18.07, Open: $17.57 ; Previous Close: $17.86 ; High: $19.09 ; Low: $17.52 ; 52 Week High: $29.74 ; 52 Week Low: $16.55. The stock opens at $17.57, after a previous close of $17.86. The stock reached a daily high of $19.09 and a low of $17.52, with a 52-week high of $29.74 and a 52-week low of $16.55.

Can Indians buy Rapport Therapeutics shares?

Yes, Indians can invest in the Rapport Therapeutics (RAPP) from India.

With INDmoney, you can buy Rapport Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rapport Therapeutics at zero transaction cost.

How can I buy Rapport Therapeutics shares from India?

It is very easy to buy Rapport Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rapport Therapeutics be purchased?

Yes, you can buy fractional shares of Rapport Therapeutics with INDmoney app.

What are the documents required to start investing in Rapport Therapeutics stocks?

To start investing in Rapport Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rapport Therapeutics

Today’s highest price of Rapport Therapeutics (RAPP) is $19.09.

Today’s lowest price of Rapport Therapeutics (RAPP) is $17.52.

What is today's market capitalisation of Rapport Therapeutics

Today's market capitalisation of Rapport Therapeutics RAPP is 762.3M

What is the 52 Week High and Low Range of Rapport Therapeutics

  • 52 Week High

    $29.74

  • 52 Week Low

    $16.55

What are the historical returns of Rapport Therapeutics?

  • 1 Month Returns

    -19.76%

  • 3 Months Returns

    -18.97%

  • 1 Year Returns

    -13.12%

  • 5 Years Returns

    -13.12%

Who is the Chief Executive Officer (CEO) of Rapport Therapeutics

Dr. Steven M. Paul M.D. is the current Chief Executive Officer (CEO) of Rapport Therapeutics.